Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells

Kopp, F., Hermawan, A., Oak, P. S., Ulaganathan, V. K., Herrmann, A., Elnikhely, N., et al. (2014). Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells. TRANSLATIONAL ONCOLOGY, 7(6), 702-711. doi:10.1016/j.tranon.2014.09.002.

Item is

Dateien

einblenden: Dateien
ausblenden: Dateien
:
1-s2.0-S1936523314000953-main.pdf (beliebiger Volltext), 2MB
Name:
1-s2.0-S1936523314000953-main.pdf
Beschreibung:
-
OA-Status:
Sichtbarkeit:
Öffentlich
MIME-Typ / Prüfsumme:
application/pdf / [MD5]
Technische Metadaten:
Copyright Datum:
-
Copyright Info:
open access article
Lizenz:
-

Externe Referenzen

einblenden:

Urheber

einblenden:
ausblenden:
 Urheber:
Kopp, Florian1, Autor
Hermawan, Adam1, Autor
Oak, Prajakta Shirish1, Autor
Ulaganathan, Vijay Kumar1, Autor
Herrmann, Annika1, Autor
Elnikhely, Nefertiti1, Autor
Thakur, Chitra1, Autor
Xiao, Zhiguang2, Autor           
Knyazev, Pjotr2, Autor           
Ataseven, Beyhan1, Autor
Savai, Rajkumar1, Autor
Wagner, Ernst1, Autor
Roidl, Andreas1, Autor
Affiliations:
1external, ou_persistent22              
2Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565172              

Inhalt

einblenden:
ausblenden:
Schlagwörter: BREAST-CANCER CELLS; MIR-200 FAMILY; MESENCHYMAL TRANSITION; DOWN-REGULATION; DRUG-RESISTANCE; REPRESSORS ZEB1; UP-REGULATION; EMT; CISPLATIN; MIGRATION
 Zusammenfassung: Acquiring therapy resistance is one of the major obstacles in the treatment of patients with cancer. The discovery of the cancer stem cell (CSC)-specific drug salinomycin raised hope for improved treatment options by targeting therapy-refractory CSCs and mesenchymal cancer cells. However, the occurrence of an acquired salinomycin resistance in tumor cells remains elusive. To study the formation of salinomycin resistance, mesenchymal breast cancer cells were sequentially treated with salinomycin in an in vitro cell culture assay, and the resulting differences in gene expression and salinomycin susceptibility were analyzed. We demonstrated that long-term salinomycin treatment of mesenchymal cancer cells resulted in salinomycin-resistant cells with elevated levels of epithelial markers, such as E-cadherin and miR-200c, a decreased migratory capability, and a higher susceptibility to the classic chemotherapeutic drug doxorubicin. The formation of salinomycin resistance through the acquisition of epithelial traits was further validated by inducing mesenchymal-epithelial transition through an overexpression of miR-200c. The transition from a mesenchymal to a more epithelial-like phenotype of salinomycin-treated tumor cells was moreover confirmed in vivo, using syngeneic and, for the first time, transgenic mouse tumor models. These results suggest that the acquisition of salinomycin resistance through the clonal selection of epithelial-like cancer cells could become exploited for improved cancer therapies by antagonizing the tumor-progressive effects of epithelial-mesenchymal transition.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 2014
 Publikationsstatus: Erschienen
 Seiten: 10
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: ISI: 000354372600007
DOI: 10.1016/j.tranon.2014.09.002
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: TRANSLATIONAL ONCOLOGY
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA : ELSEVIER SCIENCE INC
Seiten: - Band / Heft: 7 (6) Artikelnummer: - Start- / Endseite: 702 - 711 Identifikator: ISSN: 1944-7124